Ticker Details
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date:	December 31, 1981
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$121.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 0.93%
Avg Daily Range (30 D):	$0.57 | 0.98%
Avg Daily Range (90 D):	$0.57 | 0.97%

Institutional Daily Volume
Avg Daily Volume:	9.37M
Avg Daily Volume (30 D):	7.15M
Avg Daily Volume (90 D):	8.86M

Trade Size
Avg Trade Size (Sh.):	175
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	85

Institutional Trades
Total Institutional Trades:	129,723
Avg Institutional Trade:	$5.14M
Avg Institutional Trade (30 D):	$8.64M
Avg Institutional Trade (90 D):	$9.68M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	22

Market Closing Trades
Avg Closing Trade:	$57.94M
Avg Closing Trade (30 D):	$102.3M
Avg Closing Trade (90 D):	$129.85M
Avg Closing Volume:	1.08M

News

May 22, 2026 @ 9:00 AM BioNTech to Showcase Progress Across Late-Stage On... Source: Biontech Se

May 22, 2026 @ 9:00 AM BioNTech präsentiert auf der ASCO-Jahrestagung ... Source: Biontech Se

May 21, 2026 @ 11:05 AM The Most Undervalued Healthcare Stock in the S&P 5... Source: Jeff Siegel

May 20, 2026 @ 6:18 PM Anthropic And OpenAI--Building Different Competiti... Source: Opeyemi Babalola

May 20, 2026 @ 5:09 PM Bristol-Myers Squibb-Anthropic AI Deal Targets Fas... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.47	$.54	$3.47
Diluted EPS	$3.46	$.53	$3.46
Revenue	$48.19B	$12.5B	$48.19B
Gross Profit	$34.26B	$8.41B	$34.26B
Net Income / Loss	$7.06B	$1.09B	$7.06B
Operating Income / Loss	$9.33B	$1.47B	$9.33B
Cost of Revenue	$13.94B	$4.1B	$13.94B
Net Cash Flow	$-129M	$-5508M	$-129M
PE Ratio